Designing and evaluation of mupirocin-bFGF co-loaded biodegradable antimicrobial gelatin-chitosan sponge for topical wound management in rat model

设计和评价负载莫匹罗星-bFGF共载生物可降解抗菌明胶-壳聚糖海绵在大鼠模型局部伤口管理中的应用

阅读:1

Abstract

INTRODUCTION: Wound dressings help to prevent the wound from being infected and allow gaseous exchange, along with absorbing excessive wound exudates. Open wounds are very prone to bacterial infection, mostly Staphylococcus aureus may hinder the healing rate. Therefore, a fast, safe, effective, biodegradable antimicrobial wound dressing material needs to be developed. In this research, a basic fibroblast growth factor and mupirocin co-loaded biodegradable polymeric sponge was developed and evaluated for wound dressing applications. METHODS: An Antimicrobial gelatin-chitosan sponge was prepared by the surfactant foaming method. Different combinations were prepared and evaluated for water uptake, digestibility, porosity, folding endurance, morphology, FT-IR analysis, drug-loading, entrapment efficiency, in-vitro drug release, antimicrobial study, in-vivo study using rat excision model, along with histological analysis. RESULTS: The Developed sponge was found with satisfactory water uptake capacity (76.96 ± 0.79%), porosity (71.64 ± 0.7), and folding endurance (251.33 ± 4.33%), and was completely digested. Microscopy confirms the internal porous structure. Drug loading and entrapment efficiency of the final formulation were found to be 1.859 ± 0.024% and 92.95 ± 1.09%, respectively. The formulation releases 88.018 ± 3.12% mupirocin in 5 hours and best fitted in the Korsmeyer-Peppas kinetic model with a non-Fickian transport mechanism. Antimicrobial studies show a zone of inhibition of 37±2.65 mm. The wound healing study and histological studies of the formulation showed accelerated wound contraction and healing efficacy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。